Sharing Life Sciences Innovations
From scientist to entrepreneur: how a Belgian chromatography company came to be
Pharmafluidics is a Belgian company rethinking the fundamentals of liquid chromatography. Introducing a fundamentally new type of stationary phase in its chip-etched columns represented a major in…
AuXin Surgery Announces the Launch of its new CADISS System for Selective Dissection in Surgery
Louvain-la-Neuve, Belgium, 7 February 2019 – AuXin Surgery, a medical device company, announces that it has obtained CE Class III certification for its novel CADISS® System for the surgery of chro…
Inari’s agricultural revolution hits Europe with a new site in Ghent
Inari, a U.S. company revolutionizing agricultural R&D, have just opened up their first overseas office in Ghent, Belgium. Partnering with Belgian life sciences and agriculture institutes VIB and …
Pharmafluidics’ new product launch steers ‘on-a-chip’ separations of complex biological samples to new heights
PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way of performing separations by creating nano-LC columns on a…
Biocartis raises EUR 55.50 million
Biocartis Group NV (the "Company" or "Biocartis"), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today that it successfully raised an amount of EUR 55.50 millio…
Are we spending too much money on cancer drugs?
November is classically the month where immunotherapy takes center stage, especially at the annual conference of the Society for Immunotherapy of Cancer (SITC, endearingly pronounced sitsie). Imm…
New laser-based medical device revolutionizes cardiovascular disease diagnosis
Imec and Ghent University have developed a unique photonic-based medical device for the screening of arterial stiffness and the diagnosis of cardiovascular diseases. The brainchild of researchers …
A microbiome solution for type 1 diabetes?
Few things unite us the way trying to help a sick child does. Children living with the burden of type 1 diabetes (T1D) is just such a case. The desire to help young patients has galvanized a globa…
Avoiding the pitfalls of clinical development as a biotech
For many decades, the pharmaceutical industry was the sole driver of innovation in healthcare. The rapid expansion of knowledge has overturned this model in recent years. Inherently risky early-st…
argenx signs billion-dollar deal with Janssen
Another Belgian biotech on the up and up: argenx just closed a billion-dollar deal with Janssen Pharmaceutica for their antibody cusatuzumab. Under the terms of the agreement, Janssen will pay arg…
Why start-ups can become mega companies in the pharma sector
In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully integrated, commercial stage biotech company. For this to happen, the hurdles that need…
Are tech investments under threat by anti-science sentiments?
In biotech, company creation is usually preceded by scientific discoveries presenting solutions to existing problems. Because of this, early stage VC investment is, at its core, a science-driven a…
Join our 20.000 subscribers and receive the monthly newsletter for free!
Upcoming events
Dr. Paul Janssen Award for Biomedical Research Issues 2019 Call for Nominations to Celebrate Champions of Science
Online nominations
Thu 03 Jan 2019 - Thu 28 Feb 2019
03 Jan 00:00
- 28 Feb 23:59
New Brunswick, N.J. – January 3, 2019 – Nominations are now being accepted for the 2019 Dr. Paul Janssen Award for Biomedical Research. This prestigious award celebrates today’s most dedicat…
Life-on-Chip: The Road from Idea to Reality
Provincial House, Provincieplein 1 3010 Leuven (Belgium)
Thu 21 Feb 2019 - Fri 22 Feb 2019
21 Feb 16:00
- 22 Feb 16:00
Combining human cells, mini-tissues and organs with nanotechnology, 3D-printing and artificial intelligence? Cross-over innovations leading to the development of novel, personalized medicines with…
Global Engage Microbiome & Probiotics Series: Europe
Rotterdam, The Netherlands (venue TBA)
Mon 20 May 2019 - Wed 22 May 2019
20 May 08:00
- 22 May 18:00
Part of the leading global microbiome and probiotics conference series, the 2019 European event will bring together more than 300 industry, academic, and investment leaders to discuss the must cut…
